ZYME Q1 2020 Earnings — Zymeworks Inc. Revenue & Financial Results | Market Cap Arena

ZYMEZymeworks Inc.

$2B

Q1 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$8M-30.7% YoY

Gross Profit

-$29M-346.8% margin

Operating Income

-$36M-433.9% margin

Net Income

-$31M-376.5% margin

EPS (Diluted)

$-0.64

QoQ Revenue Growth

+340.5%

Cash Flow

Operating Cash Flow

-$37M

Free Cash Flow

-$38M

Stock-Based Comp.

-$3M

Balance Sheet

Total Assets

$637M

Total Liabilities

$114M

Stockholders' Equity

$522M

Cash & Equivalents

$189M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$8M	$12M	-30.7%
Gross Profit	-$29M	-$6M	-416.6%
Operating Income	-$36M	-$15M	-146.5%
Net Income	-$31M	-$14M	-128.3%

Revenue Segments

Performance Milestone

$5M60%

Drug Supply Revenue

$2M26%

Other Product

$1M13%